Matthew Vesely, MD, PhD, FAAD
SESSIONS
U080 Knowing Lichenoid Dermatoses: Common Pathways and Treatments
Mar 29, 2026
•
12:00 AM - 12:00 AM
•
Bluebird 3A
U085 Immune (Dys)regulation in Autoimmune Skin Diseases
Mar 30, 2026
•
12:00 AM - 12:00 AM
•
Bluebird 3A
DISCLOSURES
Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Fees); First Tracks Biotherapeutics – Advisory Board(Fees); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Regeneron – Employee(Salary);